US Pharma MarketingThe seeming inevitability of rising healthcare costs
According to a survey of actuaries at 27 health plans covering employers and individuals on the exchanges released today, PwC estimates that healthcare costs will rise 9% in 2027. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure…
We’re getting our first signs of where healthcare costs are heading next year.
According to a survey of actuaries at 27 health plans covering employers and individuals on the exchanges
Source: Endpoints News